The weekly litigation news digest is live. Subscribe now
Solid State Forms Of Mavacamten And Process For Preparation Thereof - EP4097091
The patent EP4097091 was granted to Assia Chemical Industries on Sep 18, 2024. The application was originally filed on Jan 28, 2021 under application number EP21706793A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4097091
- Application Number
- EP21706793A
- Filing Date
- Jan 28, 2021
- Status
- Granted And Under Opposition
- Aug 15, 2024
- Publication Date
- Sep 18, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Solid-state forms of Mavacamten, including crystalline polymorphs, for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), comprising anhydrous crystalline polymorphs of Mavacamten that exhibit stable crystal structures under various conditions. These crystalline polymorphs, including Form 1 and Form 5, have distinct crystal structures and physical properties like melting point, thermal behaviors, X-ray diffraction patterns, infrared absorption fingerprint, and solid-state (13C) NMR spectra, which enable formulation optimization for pharmaceutical applications.
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (10) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents